• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

FBDIX:US

157.56 USD 2.07 1.30%

As of 09:29:30 ET on 09/22/2014.

Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)

Year To Date: +20.24% 3-Month: +10.09% 3-Year: +43.36% 52-Week Range: 113.18 - 162.37
1-Month: +2.97% 1-Year: +25.49% 5-Year: +26.34% Beta vs SPX: 1.08

Mutual Fund Chart for FBDIX

No chart data available.
  • FBDIX:US 157.56
  • 1M
  • 1Y
Interactive FBDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBDIX

Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.

Inception Date: 09-15-1997 Telephone: 1-800-632-2301
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.com

Fundamentals for FBDIX

NAV (on 2014-09-22) 157.56
Assets (M) (on 2014-08-29) 1,579.48
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for FBDIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-16) 1.58
Dividend Yield (ttm) 5.58

Fees & Expenses for FBDIX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.59
Redemption Fee 0.00
12b1 Fee 0.30
Expense Ratio 1.10

Top Fund Holdings for FBDIX

Filing Date: 06/30/2014
Name Position Value % of Total
Gilead Sciences Inc 1,543,800 127,996,458 8.824%
Biogen Idec Inc 344,461 108,611,998 7.488%
Celgene Corp 1,215,400 104,378,552 7.196%
Amgen Inc 607,000 71,850,590 4.953%
Medivation Inc 887,954 68,443,494 4.718%
Regeneron Pharmaceuticals Inc 205,809 58,134,868 4.008%
Illumina Inc 267,900 47,830,866 3.297%
Incyte Corp 779,100 43,972,404 3.031%
Alexion Pharmaceuticals Inc 253,700 39,640,625 2.733%
Vertex Pharmaceuticals Inc 398,800 37,758,384 2.603%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil